Page last updated: 2024-11-05

tert-amyl alcohol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methylbutan-2-ol : A tertiary alcohol that is propan-1-ol in which both of the hydrogens at position 1 have been replaced by methyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6405
CHEMBL ID44658
CHEBI ID132750
MeSH IDM0101982

Synonyms (105)

Synonym
tert-pentanol
tert-isoamyl alcohol
nsc-25498
tert-amyl alcohol
t-amyl alcohol
dimethyl ethyl carbinol
nsc25498
tert-pentyl alcohol
3-methylbutan-3-ol
2-methyl butanol-2
tert-n-amyl alcohol
2-methyl-2-butanol
2-butanol, 2-methyl-
75-85-4
wln: qx2&1&1
ethyl dimethyl carbinol
amylene hydrate
1,1-dimethyl-1-propanol
D02931
amylene hydrate (nf)
ai3-24191
dimethylethylcarbinol
amylene hydrate [usan]
amylalkohol, tertiaerer
brn 1361351
einecs 200-908-9
t-pentyl alcohol
amylenum hydratum
nsc 25498
ethyldimethylcarbinol
hsdb 5005
3-methyl-butanol-(3) [german]
2-methylbutan-2-ol
inchi=1/c5h12o/c1-4-5(2,3)6/h6h,4h2,1-3h
2-butanol,2-methyl
NCGC00166208-01
2-methyl-2-butanol, reagentplus(r), 99%
2-methyl-2-butanol, reagentplus(r), >=99%
CHEBI:132750
2m2b
5A800302-5F41-4E10-9197-D3B0BD85C237
CHEMBL44658
P0059
AKOS000119037
A838528
HMS3264I17
cas-75-85-4
tox21_302356
dtxcid8021436
NCGC00255665-01
dtxsid0041436 ,
nsc-760354
nsc760354
pharmakon1600-01301017
3-methyl-butanol-(3)
unii-69c393r11z
amylene hydrate [nf]
4-01-00-01668 (beilstein handbook reference)
69c393r11z ,
ec 200-908-9
FT-0612915
amylene hydrate [hsdb]
pentyl alcohol, tert-
tert-pentyl alcohol [mi]
amylene hydrate [mart.]
CCG-213670
c2h5c(ch3)2oh
methyl-3 butanol-3
methyl-2 butanol-2
1,1-dimethylpropanol
tert-amyl-alcohol
3-hydroxy-3-methyl butane
tert. amylalcohol
tertpentanol
tert.-amyl alcohol
2-methyl-butan-2-ol
2-methyl-2butanol
methyl-tert-butyl alcohol
tertiary amylalcohol
tertiary amyl alcohol
tert.-amylalcohol
tertamyl alcohol
tert-amylalcohol
C21401
AB01563165_01
25-85-4
J-510046
F0001-1906
2-methyl-2-butanol, anhydrous, >=99%
mfcd00004478
2-methyl-2-butanol, analytical standard
t-amyl alchohol, pharmaceutical secondary standard; certified reference material
amylenhydrat
2-methyl-2-butanol (tert-amyl alcohol)
amylene hydrate, usan
2-ethyl-2-propanol
Q209428
2-methyl-2-butanol 100 microg/ml in acetonitrile
AMY11089
amylene-hydrate
t-amoh
tert-pentyl alcohol 2-methyl-2-butanol
E80408
EN300-19309
Z104473496

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The development of effective MN delivery formulations for hydrophobic drugs is more challenging with dosing restrictions and the use of organic solvents impacting on both the bioactivity and the kinetics of drug release."( Formulation of hydrophobic peptides for skin delivery via coated microneedles.
Birchall, JC; Coulman, SA; Dayan, CM; Hanna, SJ; Wong, FS; Zhao, X, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
protic solventA polar solvent that is capable of acting as a hydron (proton) donor.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
aliphatic alcoholAn alcohol derived from an aliphatic compound.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1393289Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393290Antibacterial activity against Enterococcus faecalis ATCC 19433 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393287Antibacterial activity against Escherichia coli C3000 ATCC 15597 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1145366Octanol-water partition coefficient, log P of the compound1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Application of SCAP to drug design. 1. Prediction of octanol-water partition coefficients using solvent-dependent conformational analyses.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID1393288Antibacterial activity against Staphylococcus aureus assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (10.77)18.7374
1990's9 (13.85)18.2507
2000's15 (23.08)29.6817
2010's25 (38.46)24.3611
2020's9 (13.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 64.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index64.62 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index105.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (64.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.52%)5.53%
Reviews3 (4.55%)6.00%
Case Studies1 (1.52%)4.05%
Observational0 (0.00%)0.25%
Other61 (92.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]